Department of Clinical Laboratory Center, Affiliated Hospital of Nantong University, Nantong Medical College, Nantong University, Nantong 226001, PR China.
Oncol Rep. 2012 Nov;28(5):1613-8. doi: 10.3892/or.2012.1980. Epub 2012 Aug 22.
A proliferation-inducing ligand (APRIL) is a key factor involved in the tumor development and progression in some tumor tissues and cells. Its overexpression and as gene target in SW480 colon carcinoma cells was confirmed in our previous study. To seek a more potent way to treat colon carcinoma using a gene therapy method, herein, we constructed a multiple short hairpin RNA (shRNA) expression vector containing four shRNAs against the APRIL gene in SW480 cells. APRIL expression levels and cell biological behavior were detected after transfection with different kinds of vectors. As expected, we found that our multiple shRNA vector produced a more significant knockdown effect of APRIL than the vectors containing only one APRIL shRNA. Furthermore, our findings indicate that silencing APRIL expression in SW480 cells decreased their malignancy by reducing proliferation, invasion and adhesion, as well as inducing apoptosis. Based on our findings, vectors containing multiple shRNAs to silence the expression of APRIL may be exploited as a novel therapeutic strategy for tumors.
增殖诱导配体 (APRIL) 是一些肿瘤组织和细胞中肿瘤发生和进展的关键因素。在我们之前的研究中已经证实,其在 SW480 结肠癌细胞中的过表达和基因靶点。为了寻求一种更有效的基因治疗方法来治疗结肠癌,我们构建了一个包含针对 APRIL 基因的四个短发夹 RNA (shRNA) 的多短发夹 RNA (shRNA) 表达载体。转染不同载体后,检测 APRIL 表达水平和细胞生物学行为。正如预期的那样,我们发现我们的多 shRNA 载体对 APRIL 的敲低效果比仅包含一个 APRIL shRNA 的载体更显著。此外,我们的研究结果表明,沉默 SW480 细胞中 APRIL 的表达通过降低增殖、侵袭和黏附以及诱导细胞凋亡来降低其恶性程度。基于我们的研究结果,沉默 APRIL 表达的多 shRNA 载体可能被用作肿瘤的一种新的治疗策略。